Symposiums

The FASIT meetings ensure conversations do not remain as just academic discussions in ivory towers, but are shared widely throughout the world

A Task Force was established with the objective of addressing the need for improved knowledge regarding treatment of infants with CMPA.

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.

The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…

Prof Munshi opened the presentation with a brief video highlighting the interaction of myeloma cells with the bone microenvironment…

The symposium reviewed the challenges in providing dialysis to patients with kidney disease and outlined data supporting the effectiveness of home…

In many European countries, high-volume online haemodiafiltration (OL-HDF) is becoming the method of choice for treating patients with chronic kidney…